ASCLS eNewsBytes

• Premature Blood Stem Cell Aging in Sickle Cell Disease May Be Reversible August 4, 2026
  Sickle cell disease leads to premature aging of blood stem cells, potentially addressable with a specific class of drugs, as indicated by a recent study. Affected patients show increased rates of stem cell dysfunction and blood cancers, with the underlying reasons previously unknown.
• Breast Cancer Metastases Presenting as Musculoskeletal Complaints August 4, 2026
  Breast cancer often metastasizes to the bone, leading to musculoskeletal symptoms that may mimic benign conditions. Patients with undiagnosed or recurrent malignancies may initially present to first-contact providers, including chiropractors, with non-specific spinal or musculoskeletal pain. Here, we extend the series with two additional cases, highlighting risks of delayed diagnosis, the role of imaging, and […]
• FDA Just Approved a New Targeted Lung Cancer Drug August 4, 2026
  The U.S. Food and Drug Administration has approved Jideytro for adult patients with locally advanced or metastatic ROS1-positive non-small cell lung cancer who have received at least one prior ROS1 kinase inhibitor.
• Cruise Ship Outbreak Highlights Need for Clear Communication On Emerging Disease Threats August 4, 2026
  A small outbreak of a rare hantavirus on a cruise ship earlier this year raised worldwide attention and concerns about a potential pandemic. However, it posed little risk to the general public and provides valuable lessons for health officials, scientists and the media regarding communication during emerging disease events.
• Study Uncovers Molecular Connections Between COVID-19 and PAH August 4, 2026
  COVID-19 and pulmonary arterial hypertension potentially share molecular mechanisms, which may account for their common features. This study suggests a framework for investigating these mechanisms and prioritizing future therapeutic strategies targeting both conditions.